Search

Home > Lung Cancer Considered > FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC
Podcast: Lung Cancer Considered
Episode:

FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC
Category: Science & Medicine
Duration: 00:45:33
Publish Date: 2025-07-18 13:00:28
Description: FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC
Total Play: 0